The global medical 3D printing plastics market size was US$ 1.6 billion in 2021. The global 3D printing plastics market is forecast to grow to US$ 3.9 billion by 2030, registering a compound annual ...

Severe COVID-19 arises in part from the SARS-CoV-2 virus's impact on mitochondria, tiny oxygen-burning power plants in cells, ...

Troy Matthysen (17) remains in critical condition after surgery for brain fluid leakage caused by complications from a rare disease.

NewZNew - Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of ...

Dr. Reddy's Laboratories launches Toripalimab in India, a groundbreaking treatment for metastatic and recurrent ...

Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging ...

Dr. Reddy's launches Loqtorzi biosimilar in India under the brand name Zytorvi for treating adults with recurrent or ...

In 2023, Dr Reddy's signed a licensing and commercialization agreement with Shanghai Junshi Biosciences for Toripalimab which ...

Dr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic ...

In 2023, Dr. Reddy's entered into a license and commercialisation agreement with Shanghai Junshi Biosciences Co. Ltd for ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...

Dr. Reddy's launches immuno-oncology drug Toripalimab in India for nasopharyngeal carcinoma, expanding access to innovative treatment.